Literature DB >> 17230524

Isolation of two regions on rat chromosomes 5 and 18 affecting mammary cancer susceptibility.

Daniel Stieber1, Géraldine Piessevaux, Michèle Rivière, Jean-François Laes, Xiaojiang Quan, Josiane Szpirer, Claude Szpirer.   

Abstract

We previously mapped several quantitative trait loci (QTLs) controlling DMBA-induced mammary tumor development in female rats derived from a SPRD-Cu3 (susceptible strain) x WKY (resistant strain) cross. Two of these QTLs were assigned to chromosomes 5 and 18. In the present study, we generated and characterized congenic strains in which a segment of WKY chromosomes 5 or 18 was introduced in the SPRD-Cu3 genetic background, thereby physically demonstrating that each of these two chromosomes controls mammary tumor multiplicity. The chromosome 5 QTL (Mcstm1) accounts for 7 tumors per animal (versus a total of 11 tumors per SPRD-Cu3 rat). The chromosome 18 QTL (Mcstm2) accounts for 3 tumors per animal and is the first chemically-induced mammary cancer susceptibility locus assigned to this chromosome. In addition, the Mcstm1 region was shown to also controls tumor latency. These loci thus play a major role in chemically-induced mammary tumor development. QTLs controlling chemically-induced or estrogen-induced mammary tumor development have independently been identified on chromosomes 5 and 18, using susceptible strains others than SPRD-Cu3. Therefore the haplotype structure of the relevant chromosome regions was analyzed in the different strains. Some chromosome regions were found to be highly mosaic (haplotype blocks < 1 Mb), while one region showed an apparently conserved haplotype block of 7.5 Mb. This analysis points to limited regions that could harbor the causative genes and also indicates that at least Mcstm2 is a novel QTL. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17230524     DOI: 10.1002/ijc.22400

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.

Authors:  James L Miller; Arianna P Bartlett; Rebecca M Harman; Prabin Dhangada Majhi; D Joseph Jerry; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-07-29       Impact factor: 2.698

2.  Contrasting epistatic interactions between rat quantitative trait loci controlling mammary cancer development.

Authors:  Géraldine Piessevaux; Virginie Lella; Michèle Rivière; Daniel Stieber; Pierre Drèze; Josiane Szpirer; Claude Szpirer
Journal:  Mamm Genome       Date:  2008-12-04       Impact factor: 2.957

3.  Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.

Authors:  Beverly S Schaffer; Kristin M Leland-Wavrin; Scott G Kurz; John A Colletti; Nicole L Seiler; Christopher L Warren; James D Shull
Journal:  Cancer Prev Res (Phila)       Date:  2012-11-14

Review 4.  Mammary cancer susceptibility: human genes and rodent models.

Authors:  Claude Szpirer; Josiane Szpirer
Journal:  Mamm Genome       Date:  2007-12-01       Impact factor: 2.957

5.  BAC CGH-array identified specific small-scale genomic imbalances in diploid DMBA-induced rat mammary tumors.

Authors:  Emma Samuelson; Sara Karlsson; Karolina Partheen; Staffan Nilsson; Claude Szpirer; Afrouz Behboudi
Journal:  BMC Cancer       Date:  2012-08-15       Impact factor: 4.430

6.  Genome-Wide Analysis Identifies Germ-Line Risk Factors Associated with Canine Mammary Tumours.

Authors:  Malin Melin; Patricio Rivera; Maja Arendt; Ingegerd Elvers; Eva Murén; Ulla Gustafson; Mike Starkey; Kaja Sverdrup Borge; Frode Lingaas; Jens Häggström; Sara Saellström; Henrik Rönnberg; Kerstin Lindblad-Toh
Journal:  PLoS Genet       Date:  2016-05-09       Impact factor: 5.917

7.  Significant overlap between human genome-wide association-study nominated breast cancer risk alleles and rat mammary cancer susceptibility loci.

Authors:  Jennifer Sanders; David J Samuelson
Journal:  Breast Cancer Res       Date:  2014-01-27       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.